RT Journal Article
SR Electronic
T1 THE USE OF BOTULINUM TOXIN FOR SPASTICITY IN PEOPLE AFFECTED BY SPINAL CORD INJURY: A SCOPING REVIEW PROTOCOL
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.03.30.24304908
DO 10.1101/2024.03.30.24304908
A1 Alessandro, Zadra
A1 Daniel, Feller
A1 Irene, Maini
A1 Michele, Zarbo
A1 Jacopo, Bonavita
YR 2024
UL http://medrxiv.org/content/early/2024/03/30/2024.03.30.24304908.abstract
AB Introduction Up to 80% of individuals affected by Spinal Cord Injury (SCI) develops spasticity, both in the acute and chronic phases. Botulinum NeuroToxin (BoNT) injections have been proven to be an effective intervention to treat focal spasticity in Stroke, Cerebral Palsy and Multiple Sclerosis. However, to the best of our knowledge, only one systematic review published in 2015 evaluated the efficacy of BoNT in treating spasticity in patients affected by SCI.Objective We formulated the following research question: “What is known from the existing literature about the use of BoNT for treating spasticity in patients affected by SCI?”.Material and methods We will include studies focusing on using BoNT to treat spasticity in patients with SCI due to any cause. We will search the following databases: MEDLINE (via PubMed), Embase, CENTRAL, Scopus, and PEDro. In addition, grey literature and the reference lists of all relevant studies will be searched. Two authors will independently perform the study selection and data extraction phases. Results from the scoping review will be summarized descriptively through tables and diagrams.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study will not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work will be contained in the final manuscript